New eye drops aim to soothe stubborn dry eye
NCT ID NCT07234318
First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study tested cyclosporin 0.1% eye drops in 25 adults with moderate to severe dry eye disease that didn't get better with artificial tears. The goal was to see if the drops reduce eye dryness and redness. Participants used the drops alongside their usual tear substitutes for 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cyclosporin 0.1% eye drops
- What this could lead to
- If successful, this could provide a new treatment option for people with moderate to severe dry eye disease that hasn't improved with artificial tears.
- What could go wrong
- This is a small, completed study with only 25 participants. Results may not apply to everyone with dry eye, and cyclosporin eye drops can cause stinging or irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Vienna
Vienna, 1090, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can acne drug harm the eyes? new study investigates
- Which eye drop wins the dry eye battle? a Head-to-Head test
- Can a new eye drop soothe dry eye? a trial puts TRYPTYR to the test
- New eye drop aims to soothe dryness after cataract surgery
- Can simple eye drops soothe dry eyes? new study puts OTC brands to the test
- New eye drop hopes to soothe dry eye sufferers